SAM
CSII

Silvercrest Asset Management’s Cardiovascular Systems, Inc. CSII Stock Holding History

Silvercrest Asset Management’s Portfolio CSII Stock Details CSII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-234,168
Closed -$11.4M – 802
2019
Q4 		$11.4M Sell
234,168
-1,539
-0.7% -$70.1K 0.09% 219
2019
Q3 		$11.2M Buy
+235,707
New +$11.1M 0.09% 212

Other funds holding CSII

BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Silvercrest Asset Management's CSII Position: Q1 2020 in Review

Silvercrest Asset Management sold out of Cardiovascular Systems, Inc. (CSII) in Q1 2020, closing a stake of 234,168 shares — an estimated $11.4M sold.

Silvercrest Asset Management first reported a position in CSII in Q3 2019 and held it in 2 quarters. The position peaked at $11.4M in Q4 2019. 183 funds tracked by Wall St. Rank hold CSII as of Q1 2020.

  • Silvercrest Asset Management reported no remaining Cardiovascular Systems, Inc. position as of Q1 2020 after selling out during the quarter.
  • Silvercrest Asset Management sold 234,168 Cardiovascular Systems, Inc. shares in Q1 2020, an estimated $11.4M.
  • Silvercrest Asset Management first reported a position in Cardiovascular Systems, Inc. in Q3 2019 and held it in 2 quarters.
  • Silvercrest Asset Management's Cardiovascular Systems, Inc. position peaked at $11.4M in Q4 2019.
  • 183 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q1 2020.

Based on Silvercrest Asset Management's 13F filing for Q1 2020, filed 15 May 2020.